Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Digital Diabetes Management Market, by Type
1.4.2 North America Digital Diabetes Management Market, by Product & Service
1.4.3 North America Digital Diabetes Management Market, by End User
1.4.4 North America Digital Diabetes Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Business Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018, Jun – 2022, Apr) Leading Players
Chapter 4. North America Digital Diabetes Management Market by Type
4.1 North America Wearables Market by Country
4.2 North America Handheld Devices Market by Country
Chapter 5. North America Digital Diabetes Management Market by Product & Service
5.1 North America Devices Market by Country
5.2 North America Digital Diabetes Management Market by Devices Type
5.2.1 North America Continuous Glucose Monitoring (CGM) Systems Market by Country
5.2.2 North America Smart Glucose Meters Market by Country
5.2.3 North America Smart Insulin Pens Market by Country
5.2.4 North America Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches Market by Country
5.3 North America Application Market by Country
5.4 North America Digital Diabetes Management Market by Application Type
5.4.1 North America Diabetes & Blood Glucose Tracking Apps Market by Country
5.4.2 North America Obesity & Diet Management Apps Market by Country
5.5 North America Data Management Software & Platforms Market by Country
5.6 North America Services Market by Country
Chapter 6. North America Digital Diabetes Management Market by End User
6.1 North America Self/Home Healthcare Market by Country
6.2 North America Hospitals & Specialty Diabetes Clinics Market by Country
6.3 North America Academic & Research Institutes Market by Country
Chapter 7. North America Digital Diabetes Management Market by Country
7.1 US Digital Diabetes Management Market
7.1.1 US Digital Diabetes Management Market by Type
7.1.2 US Digital Diabetes Management Market by Product & Service
7.1.2.1 US Digital Diabetes Management Market by Devices Type
7.1.2.2 US Digital Diabetes Management Market by Application Type
7.1.3 US Digital Diabetes Management Market by End User
7.2 Canada Digital Diabetes Management Market
7.2.1 Canada Digital Diabetes Management Market by Type
7.2.2 Canada Digital Diabetes Management Market by Product & Service
7.2.2.1 Canada Digital Diabetes Management Market by Devices Type
7.2.2.2 Canada Digital Diabetes Management Market by Application Type
7.2.3 Canada Digital Diabetes Management Market by End User
7.3 Mexico Digital Diabetes Management Market
7.3.1 Mexico Digital Diabetes Management Market by Type
7.3.2 Mexico Digital Diabetes Management Market by Product & Service
7.3.2.1 Mexico Digital Diabetes Management Market by Devices Type
7.3.2.2 Mexico Digital Diabetes Management Market by Application Type
7.3.3 Mexico Digital Diabetes Management Market by End User
7.4 Rest of North America Digital Diabetes Management Market
7.4.1 Rest of North America Digital Diabetes Management Market by Type
7.4.2 Rest of North America Digital Diabetes Management Market by Product & Service
7.4.2.1 Rest of North America Digital Diabetes Management Market by Devices Type
7.4.2.2 Rest of North America Digital Diabetes Management Market by Application Type
7.4.3 Rest of North America Digital Diabetes Management Market by End User
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.5.4 Business Expansions:
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Approvals and Trials:
8.3 Terumo Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Partnerships, Collaborations, and Agreements:
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.5 DexCom, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Novo Nordisk A/S
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental & Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.7 ACON Laboratories, Inc.
8.7.1 Company Overview
8.8 Bayer AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 B. Braun Melsungen AG
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.10. Azumio, Inc.
8.10.1 Company Overview
Unique Offerings 
